G. Morton

发表

Urodynamic changes at 18 months post-therapy in patients treated with external beam radiotherapy for prostate carcinoma.

C. Danjoux, G. Deboer, S. Herschorn, 2002, International journal of radiation oncology, biology, physics.

The effect of radiation technique and bladder filling on the acute toxicity of pelvic radiotherapy for localized high risk prostate cancer.

Hans T. Chung, Liying Zhang, A. Sahgal, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.

P. Halina, G. Morton, R. Sankreacha, 2008, Brachytherapy.

American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy.

J. Pouliot, I. Hsu, Y. Yamada, 2012, Brachytherapy.

Target position variability throughout prostate radiotherapy.

G Morton, K Mah, L. Dawson, 1998, International journal of radiation oncology, biology, physics.

A descriptive analysis of postimplant dosimetric parameters from Radiation Therapy Oncology Group P0019.

H. Sandler, K. Bae, M. Kuettel, 2006, Brachytherapy.

The best method for dose escalation: Prostate brachytherapy.

G. Morton, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Dosimetric evaluation of MRI-to-ultrasound automated image registration algorithms for prostate brachytherapy.

Hans T. Chung, G. Morton, A. Loblaw, 2020, Brachytherapy.

A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526).

D. Beyer, C. Catton, H. Sandler, 2017, International journal of radiation oncology, biology, physics.

Feasibility of an MRI-only workflow for postimplant dosimetry of low-dose-rate prostate brachytherapy: Transition from phantoms to patients.

William Y. Song, G. Stanisz, G. Morton, 2019, Brachytherapy.

Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.

William Y. Song, G. Morton, H. Safigholi, 2016, Brachytherapy.

Hypofractionated concomitant intensity-modulated radiotherapy boost for high-risk prostate cancer: late toxicity.

A. Kiss, P. Cheung, C. Danjoux, 2012, International journal of radiation oncology, biology, physics.

Results of a prospective multi-institutional phase II trial (RTOG 98–05) of transrectal ultrasound guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate

W. R. Lee, D. Grignon, H. Sandler, 2004 .

Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost-Utility Analysis.

P. Cheung, L. D'alimonte, M. Krahn, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Quantitative Ultrasound Spectroscopic Imaging for Characterization of Disease Extent in Prostate Cancer Patients1

Michael C. Kolios, Hans T. Chung, M. Yaffe, 2015, Translational oncology.

The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation

S. Narod, S. Herschorn, G. Morton, 2018, British Journal of Cancer.

Cancer Management and Research Dovepress Single Fraction Radiotherapy versus Multiple Fraction Radiotherapy for Bone Metastases in Prostate Cancer Patients: Comparative Effectiveness

G. Morton, F. Yoon, 2022 .

Radiation Oncology Fellowship: a Value-Based Assessment Among Graduates of a Mature Program

C. Catton, Z. Kassam, H. Soliman, 2020, Journal of Cancer Education.

MR-guided prostate biopsy for planning of focal salvage after radiation therapy.

A. Evans, K. Brock, C. Ménard, 2015, Radiology.

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy.

Hans T. Chung, Liying Zhang, P. Cheung, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase II clinical trial of one fraction of 19Gy or two fractions of 13.5Gy.

Hans T. Chung, Liying Zhang, P. Cheung, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

High dose-rate brachytherapy boost for intermediate risk prostate cancer: Long-term outcomes of two different treatment schedules and early biochemical predictors of success.

Hans T. Chung, Liying Zhang, P. Cheung, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prostate high-dose-rate brachytherapy: Transrectal ultrasound based planning, a technical note.

G. Morton, 2015, Practical radiation oncology.

Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial

J. Galvin, H. Sandler, J. Bahary, 2013 .

Absolute percentage of biopsied tissue positive for Gleason pattern 4 disease (APP4) appears predictive of disease control after high dose rate brachytherapy and external beam radiotherapy in intermediate risk prostate cancer.

P. Cheung, E. Szumacher, D. Vesprini, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer.

Hans T. Chung, A. Kiss, A. Bezjak, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.

Liying Zhang, K. Sixel, R. Tirona, 2008, International journal of radiation oncology, biology, physics.

Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapy.

Hans T. Chung, M. Haider, J. Murgić, 2018, Brachytherapy.

Canadian consensus definition of prostate cancer risk stratification

W. J. Morris, M. Keyes, É. Vigneault, 2013 .

Conventional vs machine learning-based treatment planning in prostate brachytherapy: Results of a Phase I randomized controlled trial.

Hans T. Chung, G. Morton, A. Loblaw, 2020, Brachytherapy.

Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.

P. Cheung, C. Danjoux, E. Szumacher, 2007, European urology.

Salvage radiotherapy following biochemical relapse after radical prostatectomy: proceedings of the Genito-Urinary Radiation Oncologists of Canada consensus meeting.

P. Warde, T. Pickles, G. Morton, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy.

P. Cheung, C. Danjoux, E. Szumacher, 2006, International journal of radiation oncology, biology, physics.

Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging.

P. Cheung, G. Morton, D. Loblaw, 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

Radiation Oncologist Consultations Prior to Radical Prostatectomy: Disparities and Opportunities

J. Chin, B. Fisher, R. Saskin, 2021, Journal of Urology.

ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.

W. J. Morris, M. Keyes, G. Duncan, 2017, International journal of radiation oncology, biology, physics.

Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function

R. Gray, C. Danjoux, S. Gardner, 2010, Supportive Care in Cancer.

Prostate cancer radiotherapy 2002: the way forward.

C. Catton, P. Warde, T. Pickles, 2005, The Canadian journal of urology.

Three-dimensional ultrasound-based spectroscopic imaging for detection of prostate cancer in men.

M. Yaffe, G. Czarnota, L. Sugar, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy.

Hans T. Chung, G. Pond, M. Lock, 2019, International journal of radiation oncology, biology, physics.

Prostate high dose-rate brachytherapy as monotherapy for prostate cancer: late toxicity and patient reported outcomes from a randomized phase II clinical trial.

Hans T. Chung, Liying Zhang, P. Cheung, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term outcome of postorchiectomy surveillance for Stage I testicular seminoma.

L. Klotz, C. Danjoux, N. Iscoe, 2005, International journal of radiation oncology, biology, physics.

Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.

P. Cheung, C. Danjoux, E. Szumacher, 2009, International journal of radiation oncology, biology, physics.

Effect of androgen suppression on hemoglobin in prostate cancer patients undergoing salvage radiotherapy plus 2-year buserelin acetate for rising PSA after surgery.

P. Cheung, C. Danjoux, E. Szumacher, 2005, International journal of radiation oncology, biology, physics.

Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.

Hans T. Chung, L. D'alimonte, J. Murgić, 2017, Brachytherapy.

A Comparative Study of Quality of Life in Patients with Localized Prostate Cancer Treated in a Single Institution: Stereotactic Radiotherapy or External Beam + High-Dose-Rate Brachytherapy Boost

Hans T. Chung, Liying Zhang, P. Cheung, 2014 .

Evaluating the tolerability of a simultaneous focal boost to the gross tumour in prostate SABR: a toxicity and quality of life comparison of two prospective trials.

P. Cheung, L. D'alimonte, N. Mittmann, 2020, International journal of radiation oncology, biology, physics.

Comparison of Biochemical and Toxicity Outcomes From a Contemporaneous Cohort Study of Low-Risk Prostate Cancer Treated With Different Radiation Techniques

Hans T. Chung, P. Cheung, L. D'alimonte, 2013 .

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cance

W. J. Morris, G. Duncan, S. Tyldesley, 2017, International journal of radiation oncology, biology, physics.

Quality assurance methods for the first Radiation Therapy Oncology Group permanent prostate implant protocol.

G. Ibbott, J. Michalski, M. Gillin, 2006, Brachytherapy.

How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients?

P. Cheung, C. Danjoux, E. Szumacher, 2005, The Canadian journal of urology.

Prospective Evaluation of Gastrointestinal (GI) and Genitourinary (GU) Toxicity of Salvage Radiotherapy (RT) to the Prostate Bed for Patients with PSA Relapse after Radical Prostatectomy (RP)

P. Cheung, C. Danjoux, E. Szumacher, 2008 .

Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis.

Hans T. Chung, G. Rodrigues, A. Warner, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients.

P. Cheung, E. Szumacher, D. Vesprini, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Elective nodal ultra hypofractionated radiation for prostate cancer: safety and efficacy from four prospective clinical trials.

Hans T. Chung, Liying Zhang, P. Cheung, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pattern of relapse and dose received by the recurrent intraprostatic nodule in low- to intermediate-risk prostate cancer treated with single fraction 19 Gy high-dose-rate brachytherapy.

Hans T. Chung, P. Cheung, M. McGuffin, 2017, Brachytherapy.

High Dose Rate Brachytherapy in High-Risk Localised Disease - Why Do Anything Else?

G. Morton, S. Alrashidi, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

PD20-08 THE EFFECT OF SELECTION AND REFERRAL BIASES FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER WITH SURGERY OR RADIATION

S. Narod, S. Herschorn, G. Morton, 2018 .

Hans T. Chung, Liying Zhang, P. Cheung, 2011, International journal of radiation oncology, biology, physics.

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial

H. Sandler, M. Lock, J. Purdy, 2018, JAMA oncology.

MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML).

Reyhaneh Nosrati, Abraam Soliman, Habib Safigholi, 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Neil Fleshner, L. Klotz, N. Fleshner, 2002, The Journal of urology.

PSA doubling time of prostate carcinoma managed with watchful observation alone.

E. Rakovitch, L. Klotz, N. Fleshner, 2001, International journal of radiation oncology, biology, physics.

Pharmacokinetics of mercaptopurine: plasma drug and red cell metabolite concentrations after an oral dose.

J. Lilleyman, G. Morton, L. Lennard, 1997, Therapeutic drug monitoring.

Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for post-radical prostatectomy patients with pathologic T3 disease and/or positive surgical margins.

P. Cheung, C. Danjoux, E. Szumacher, 2008, International journal of radiation oncology, biology, physics.

Treatment options for localized prostate cancer.

Nawaid Usmani, Mira Keyes, W James Morris, 2013, Canadian family physician Medecin de famille canadien.

Canadian prostate brachytherapy in 2012.

Nawaid Usmani, Tom Pickles, Mira Keyes, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Adjuvant Versus Salvage Radiotherapy for Patients With Adverse Pathological Findings Following Radical Prostatectomy: A Decision Analysis

D. Naimark, E. Szumacher, A. Jerath, 2017, MDM policy & practice.

Wide variation of prostate‐specific antigen doubling time of untreated, clinically localized, low‐to‐intermediate grade, prostate carcinoma

L. Klotz, C. Danjoux, G. Deboer, 2004, BJU international.

Adjuvant radiotherapy following radical prostatectomy: Genito-Urinary Radiation Oncologists of Canada Consensus Statement.

P. Warde, T. Pickles, G. Morton, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

The effect of selection and referral biases for the treatment of localised prostate cancer with surgery or radiation

S. Narod, S. Herschorn, G. Morton, 2018, British Journal of Cancer.

Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy.

P. Cheung, Colin Tang, G. Morton, 2012, The Canadian journal of urology.

Low-dose metronomic daily cyclophosphamide and weekly tirapazamine: a well-tolerated combination regimen with enhanced efficacy that exploits tumor hypoxia.

R. Kerbel, Y. Shaked, Marcela Franco, 2006, Cancer research.

ASCENDE-RT*: A multicenter, randomized trial of dose-escalated external beam radiation therapy (EBRT-B) versus low-dose-rate brachytherapy (LDR-B) for men with unfavorable-risk localized prostate cancer.

W. J. Morris, G. Duncan, S. Tyldesley, 2015 .

Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion - results from the 2SMART Phase 2 trial.

Liying Zhang, P. Cheung, M. McGuffin, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Clinical evaluation of an MRI-to-ultrasound deformable image registration algorithm for prostate brachytherapy.

Ananth Ravi, Melanie Davidson, Chia-Lin Tseng, 2019, Brachytherapy.

Long-term results of a study using individualized planning target volumes for hypofractionated intensity-modulated radiotherapy boost for prostate cancer

Kelvin K. W. Chan, P. Cheung, J. Pignol, 2015, Radiation oncology.

Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)

P. Cheung, E. Szumacher, Xingshan Cao, 2018, Journal of Cancer Education.

Late toxicity and biochemical recurrence after external‐beam radiotherapy combined with permanent‐source prostate brachytherapy

H. Sandler, M. Kuettel, M. Gillin, 2007, Cancer.

The evolution of brachytherapy for prostate cancer

Yasuo Yoshioka, Timothy N. Showalter, B. Davis, 2017, Nature Reviews Urology.

Accelerated hypofractioned postoperative radiotherapy for prostate cancer: a prospective phase I/II study.

P. Cheung, A. Gladwish, G. Morton, 2015, Clinical oncology (Royal College of Radiologists (Great Britain)).

Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer.

D Andrew Loblaw, Jean-Philippe Pignol, Patrick Cheung, 2005, International journal of radiation oncology, biology, physics.

The emerging role of high-dose-rate brachytherapy for prostate cancer.

G. Morton, G C Morton, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Overview The Emerging Role of High-dose-rate Brachytherapy for Prostate Cancer

G. Morton, 2005 .

MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial.

Laura D'Alimonte, Hans T. Chung, Ananth Ravi, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Yaqun Wang, É. Vigneault, D. Taussky, 2019, Advances in radiation oncology.

High dose-rate brachytherapy in the treatment of prostate cancer

G. Morton, L. Mendez, 2018, Translational andrology and urology.

Brachytherapy: current status and future strategies -- can high dose rate replace low dose rate and external beam radiotherapy?

P. Hoskin, G. Morton, Peter Hoskin, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

A randomized trial of 79.2Gy versus 70.2Gy radiation therapy (RT) for localized prostate cancer.

H. Sandler, M. Lock, J. Purdy, 2015 .

High Dose Rate Prostate Brachytherapy

T. Showalter, M. Harkenrider, A. Wong, 2021 .

An Updated Analysis of the Survival Endpoints of ASCENDE-RT.

W. J. Morris, M. Keyes, G. Duncan, 2022, International journal of radiation oncology, biology, physics.

Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): efficacy, toxicity and quality of life.

Liying Zhang, P. Cheung, D. Vesprini, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

5-Year Outcomes of a Prospective Phase 1/2 Study of Accelerated Hypofractionated Radiation Therapy to the Prostate Bed.

Liying Zhang, P. Cheung, A. Gladwish, 2019, Practical radiation oncology.

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.

J. Galvin, H. Sandler, W. Bosch, 2013, International journal of radiation oncology, biology, physics.

The clinical significance of persistent cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer.

Liying Zhang, G. Morton, A. Deabreu, 2015, Brachytherapy.

Controversies in prostate cancer radiotherapy: consensus development.

L Souhami, G Morton, M. Brundage, 2001, The Canadian journal of urology.

Contemporary management of prostate cancer: a practice survey of Ontario genitourinary radiation oncologists.

J. Crook, D. D'Souza, G. Rodrigues, 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

Liying Zhang, É. Vigneault, P. Cheung, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.

Liying Zhang, P. Cheung, C. Danjoux, 2010, International journal of radiation oncology, biology, physics.

Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer.

G. Rodrigues, P. Cheung, G. Morton, 2021, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Current topics in radiotherapy for genitourinary cancers: Consensus statements of the Genitourinary Radiation Oncologists of Canada.

C. Ménard, P. Warde, A. Berlin, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

A personalized decision aid for prostate cancer shared decision making

David Scheinker, Mark Buyyounouski, Radka Stoyanova, 2021, BMC Medical Informatics and Decision Making.

Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?

L. Klotz, C. Danjoux, G. Deboer, 2002, International journal of radiation oncology, biology, physics.

Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer.

P. Cheung, E. Szumacher, D. Vesprini, 2022, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Radiation treatment of bladder squamous cell carcinoma in a patient with spina bifida: A case report.

G. Morton, H. Chung, N. D'souza, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

High-dose-rate brachytherapy boost for prostate cancer: rationale and technique

G. Morton, Gerard C. Morton, 2014, Journal of contemporary brachytherapy.

Use of cone-beam imaging to correct for catheter displacement in high dose-rate prostate brachytherapy.

D Andrew Loblaw, G. Morton, D. Loblaw, 2011, Brachytherapy.

Salvage Low Dose Rate Prostate Brachytherapy: Clinical Outcomes of a Phase II Trial for Local Recurrence after External Beam Radiotherapy (NRG Oncology/xxxx).

D. Beyer, H. Sandler, É. Vigneault, 2021, International journal of radiation oncology, biology, physics.

Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05).

D. Grignon, H. Sandler, T. Pisansky, 2007, International journal of radiation oncology, biology, physics.

Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.

G Morton, P S Basran, R. Tirona, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: stereotactic ablative radiotherapy or external beam+high dose rate brachytherapy boost.

Liying Zhang, P. Cheung, G. Morton, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Testosterone recovery after prolonged androgen suppression in patients with prostate cancer.

P. Cheung, C. Danjoux, S. Gardner, 2008, The Journal of urology.

Salvage Prostate Brachytherapy in Radiorecurrent Prostate Cancer: An International Delphi Consensus Study.

I. Hsu, L. Potters, M. Zelefsky, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Defining radio-recurrent intra-prostatic target volumes using PSMA-targeted PET/CT and multi-parametric MRI

A. Ward, G. Bauman, Z. Kassam, 2021, Clinical and Translational Radiation Oncology.

Is prostate brachytherapy a dying art? Trends and variation in the definitive management of prostate cancer in ontario, canada.

J. Chin, D. D'Souza, R. Saskin, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05).

D. Grignon, H. Sandler, T. Pisansky, 2009, International journal of radiation oncology, biology, physics.

Estimating acute urinary retention risk post prostate high dose-rate (HDR) brachytherapy: A clinical-based recursive partitioning analysis.

G. Morton, A. Loblaw, A. Ravi, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial

D. Yan, H. Sandler, M. Lock, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019.

H. Sandler, M. Kuettel, M. Desilvio, 2006, International journal of radiation oncology, biology, physics.

Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.

Liying Zhang, P. Cheung, E. Szumacher, 2021, Radiotherapy and Oncology.

Single Fraction High-Dose-Rate Brachytherapy: Too Good to Be True?

P. Hoskin, G. Morton, 2019, International journal of radiation oncology, biology, physics.

Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.

Liying Zhang, M. Haider, J. Murgić, 2018, International journal of radiation oncology, biology, physics.

Clinical Investigation : Genitourinary Cancer Quality of Life After Hypofractionated Concomitant Intensity-Modulated Radiotherapy Boost for High-Risk Prostate Cancer

A. Kiss, P. Cheung, C. Danjoux, 2012 .

Potential applications of the quantitative susceptibility mapping (QSM) in MR-guided radiation therapy

Reyhaneh Nosrati, Gerard Morton, Greg Stanisz, 2019, Physics in medicine and biology.

The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines.

M. Zelefsky, M. Keyes, É. Vigneault, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Initial Results of a Phase 3 Randomized Study of High Dose 3DCRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (RTOG 0126)

H. Sandler, M. Lock, J. Purdy, 2014 .

Developing and Evaluating Multimedia Patient Education Tools to Better Prepare Prostate-Cancer Patients for Radiotherapy Treatment (Randomized Study)

P. Cheung, E. Szumacher, Xingshan Cao, 2016, Journal of Cancer Education.

Optimized penile surface mold brachytherapy using latest stereolithography techniques: A single-institution experience.

Harry Easton, Laura D'Alimonte, Ananth Ravi, 2019, Brachytherapy.

Customized Penile Plesiobrachytherapy Using Latest Stereolithography Techniques

G. Morton, A. Ravi, H. Easton, 2015 .

High-dose-rate prostate brachytherapy in a patient with bilateral hip prostheses planned using megavoltage computed tomography images acquired with a helical tomotherapy unit.

G. Morton, R. Sankreacha, S. Myrehaug, 2009, Brachytherapy.

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Liying Zhang, P. Cheung, M. McGuffin, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.

A. Evans, C. Ménard, M. Haider, 2012, International journal of radiation oncology, biology, physics.

Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program.

P. Cheung, C. Danjoux, G. Morton, 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Megavoltage cone beam digital tomosynthesis (MV-CBDT) for image-guided radiotherapy: a clinical investigational system

J A Rowlands, G Morton, P F O'Brien, 2008, Physics in medicine and biology.

Preliminary Analysis of 3D-CRT vs. IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial: Toxicity Report

J. Galvin, H. Sandler, J. Michalski, 2011 .

Long-term Toxicity and Health-related Quality of Life after Single-fraction High Dose Rate Brachytherapy Boost and Hypofractionated External Beam Radiotherapy for Intermediate-risk Prostate Cancer.

Liying Zhang, P. Cheung, C. Danjoux, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Multipurpose ultrasound-based prostate phantom for use in interstitial brachytherapy.

G. Morton, A. Loblaw, A. Ravi, 2021, Brachytherapy.

Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.

G. Morton, A. Loblaw, D. Batchelar, 2016, Brachytherapy.

Genintourinary Oncology Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer

G. Morton, A. Loblaw, D. Batchelar, 2016 .

Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma.

G. Morton, R. Sankreacha, A. Loblaw, 2006, Brachytherapy.

PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study.

É. Vigneault, D. Taussky, G. Delouya, 2021, Brachytherapy.

Prostate HDR Monotherapy: Initial Efficacy Results from a Randomized Trial of One versus Two Fractions

Liying Zhang, M. McGuffin, G. Morton, 2017 .

Evaluation of a Machine-Learning Algorithm for Treatment Planning in Prostate Low-Dose-Rate Brachytherapy.

Ananth Ravi, Emily Heath, Lin Lu, 2017, International journal of radiation oncology, biology, physics.

Expectant management with selective delayed intervention for favorable-risk prostate cancer.

L. Klotz, C. Danjoux, R. Choo, 2002, The Canadian journal of urology.

Imaging technologies for high dose rate brachytherapy for cervical cancer: a systematic review.

D. D'Souza, C. Falkson, G. Morton, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

Delivery of brachytherapy for cervical cancer: organisational and technical advice to facilitate high-quality care.

D. D'Souza, C. Falkson, G. Morton, 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

Feasibility of using a single MRI acquisition for fiducial marker localization and synthetic CT generation towards MRI-only prostate radiation therapy treatment planning

G. Stanisz, G. Morton, M. Paudel, 2021, Biomedical physics & engineering express.

Single fraction radiotherapy versus multiple fraction radiotherapy for bone metastases in prostate cancer patients : comparative effectiveness

G. Morton, F. Yoon, 2014 .

Empowering Patients Through Education—Development and Evaluation of a Multimedia Patient Education Tool to Ensure Patient Preparedness for Planning CT Scan for Prostate Cancer (Randomized Study)

P. Cheung, E. Szumacher, Xingshan Cao, 2016 .

The best method for dose escalation: Prostate brachytherapy.

G. Morton, 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using national cancer institute expanded common toxicity criteria.

P. Cheung, C. Danjoux, E. Szumacher, 2008, International journal of radiation oncology, biology, physics.

Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy.

P. Cheung, C. Danjoux, E. Szumacher, 2008, International journal of radiation oncology, biology, physics.

(IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy.

C. Danjoux, G. Deboer, Julie J. Hong, 2002, International journal of radiation oncology, biology, physics.

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer.

Liying Zhang, P. Cheung, M. McGuffin, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

How much does Gleason grade of follow‐up biopsy differ from that of initial biopsy in untreated, Gleason score 4–7, clinically localized prostate cancer?

L. Klotz, C. Danjoux, E. Szumacher, 2007, The Prostate.

Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physicians.

I. Tannock, L. Klotz, D. Cheung, 2017, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Limited efficacy of salvage radiotherapy for biopsy confirmed or clinically palpable local recurrence of prostate carcinoma after surgery.

C. Danjoux, E. Szumacher, G. Deboer, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparison of acute toxicity in patients treated with a 4-field box or IMRT to deliver elective pelvic nodal irradiation for localized high-risk prostate cancer.

Liying Zhang, A. Sahgal, P. Cheung, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2151 Watchful observation of asymptomatic, favorable grade, prostate carcinoma with selective delayed intervention based on PSA, histologic, and/or clinical progression

E. Rakovitch, L. Klotz, N. Fleshner, 1999 .

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial

G. Gustafson, D. Yan, H. Sandler, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse.

P. Cheung, C. Danjoux, E. Szumacher, 2009, International journal of radiation oncology, biology, physics.

Radiation therapy after radical surgery in prostate cancer

G. Morton, R. Paz-Manrique, Fernando Quiroa Vera, 2023, Ecancermedicalscience.

Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.

Liying Zhang, K. Sixel, R. Tirona, 2008, International Journal of Radiation Oncology, Biology, Physics.

Liying Zhang, P. Cheung, G. Morton, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.